CIPLA.NS vs. TORNTPHARM.NS

Last updated Jun 4, 2026

CIPLA.NS (Cipla Limited) and TORNTPHARM.NS (Torrent Pharmaceuticals Limited) are both stocks. Both are in the Healthcare sector — CIPLA.NS in Drug Manufacturers - General, TORNTPHARM.NS in Drug Manufacturers - Specialty & Generic. Over the past 10 years, CIPLA.NS returned 12.18%/yr vs 21.54%/yr for TORNTPHARM.NS. At a 0.24 correlation, their price movements are largely independent.

Performance

CIPLA.NS vs. TORNTPHARM.NS - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Cipla Limited (CIPLA.NS) and Torrent Pharmaceuticals Limited (TORNTPHARM.NS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CIPLA.NS achieves a -9.01% return, which is significantly lower than TORNTPHARM.NS's 14.47% return. Over the past 10 years, CIPLA.NS has underperformed TORNTPHARM.NS with an annualized return of 12.18%, while TORNTPHARM.NS has yielded a comparatively higher 21.54% annualized return.

CIPLA.NS

• 1D: -0.30%
• 1M: 3.01%
• YTD: -9.01%
• 6M: -8.81%
• 1Y: -5.66%
• 3Y*: 13.52%
• 5Y*: 8.57%
• 10Y*: 12.18%

TORNTPHARM.NS

• 1D: 1.17%
• 1M: 2.95%
• YTD: 14.47%
• 6M: 18.44%
• 1Y: 40.85%
• 3Y*: 36.45%
• 5Y*: 26.96%
• 10Y*: 21.54%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CIPLA.NS vs. TORNTPHARM.NS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CIPLA.NS Cipla Limited	-9.01%	-0.10%	23.72%	16.77%	14.52%	15.78%	73.26%	-7.42%	-14.21%	7.36%
TORNTPHARM.NS Torrent Pharmaceuticals Limited	14.47%	15.70%	47.26%	50.70%	-4.24%	18.50%	52.88%	5.41%	26.09%	8.92%

Correlation

The correlation between CIPLA.NS and TORNTPHARM.NS is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.29
Correlation (3Y) Calculated over the trailing 3-year period	0.37
Correlation (5Y) Calculated over the trailing 5-year period	0.34
Correlation (10Y) Calculated over the trailing 10-year period	0.31
Correlation (All Time) Calculated using the full available price history since Jul 2, 2002	0.24

The correlation between CIPLA.NS and TORNTPHARM.NS shifts across timeframes, from 0.24 (all time) to 0.37 (3 years), reflecting how their relationship changes across market environments.

Return for Risk

CIPLA.NS vs. TORNTPHARM.NS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CIPLA.NS

CIPLA.NS Risk / Return Rank: 29
CIPLA.NS Sharpe Ratio Rank: 29
CIPLA.NS Sortino Ratio Rank: 24
CIPLA.NS Omega Ratio Rank: 24
CIPLA.NS Calmar Ratio Rank: 34
CIPLA.NS Martin Ratio Rank: 33

TORNTPHARM.NS

TORNTPHARM.NS Risk / Return Rank: 87
TORNTPHARM.NS Sharpe Ratio Rank: 88
TORNTPHARM.NS Sortino Ratio Rank: 88
TORNTPHARM.NS Omega Ratio Rank: 85
TORNTPHARM.NS Calmar Ratio Rank: 87
TORNTPHARM.NS Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CIPLA.NS vs. TORNTPHARM.NS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cipla Limited (CIPLA.NS) and Torrent Pharmaceuticals Limited (TORNTPHARM.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CIPLA.NS	TORNTPHARM.NS	Difference
Sharpe ratio: Return per unit of total volatility	-0.27	2.02	-2.29
Sortino ratio: Return per unit of downside risk	-0.26	2.99	-3.26
Omega ratio: Gain probability vs. loss probability	0.97	1.36	-0.40
Calmar ratio: Return relative to maximum drawdown	-0.20	3.96	-4.16
Martin ratio: Return relative to average drawdown	-0.41	10.99	-11.40
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CIPLA.NS vs. TORNTPHARM.NS - Sharpe Ratio Comparison

The current CIPLA.NS Sharpe Ratio is -0.27, which is lower than the TORNTPHARM.NS Sharpe Ratio of 2.02. The chart below compares the historical Sharpe Ratios of CIPLA.NS and TORNTPHARM.NS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CIPLA.NS	TORNTPHARM.NS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.27	2.02	-2.29
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.38	1.17	-0.80
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	0.82	-0.34
Sharpe Ratio (All Time) Calculated using the full available price history	0.04	0.90	-0.86

Drawdowns

CIPLA.NS vs. TORNTPHARM.NS - Drawdown Comparison

The maximum CIPLA.NS drawdown since its inception was -99.02%, which is greater than TORNTPHARM.NS's maximum drawdown of -56.21%. Use the drawdown chart below to compare losses from any high point for CIPLA.NS and TORNTPHARM.NS.

Drawdown Indicators

	CIPLA.NS	TORNTPHARM.NS	Difference
Max Drawdown Largest peak-to-trough decline	-99.02%	-56.21%	-42.81%
Max Drawdown (1Y) Largest decline over 1 year	-28.32%	-10.32%	-18.00%
Max Drawdown (3Y) Largest decline over 3 years	-28.32%	-16.98%	-11.34%
Max Drawdown (5Y) Largest decline over 5 years	-28.32%	-22.89%	-5.43%
Max Drawdown (10Y) Largest decline over 10 years	-43.40%	-30.70%	-12.70%
Current Drawdown Current decline from peak	-17.34%	-4.27%	-13.07%
Average Drawdown Average peak-to-trough decline	-52.85%	-12.49%	-40.36%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.74%	3.72%	+10.02%

Volatility

CIPLA.NS vs. TORNTPHARM.NS - Volatility Comparison

Cipla Limited (CIPLA.NS) has a higher volatility of 9.87% compared to Torrent Pharmaceuticals Limited (TORNTPHARM.NS) at 8.02%. This indicates that CIPLA.NS's price experiences larger fluctuations and is considered to be riskier than TORNTPHARM.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CIPLA.NS	TORNTPHARM.NS	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.87%	8.02%	+1.85%
Volatility (6M) Calculated over the trailing 6-month period	16.20%	15.10%	+1.10%
Volatility (1Y) Calculated over the trailing 1-year period	20.79%	20.21%	+0.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.04%	23.44%	-0.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.79%	26.93%	-1.14%

Dividends

CIPLA.NS vs. TORNTPHARM.NS - Dividend Comparison

CIPLA.NS's dividend yield for the trailing twelve months is around 1.16%, more than TORNTPHARM.NS's 1.01% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CIPLA.NS Cipla Limited	1.16%	1.06%	0.85%	0.68%	0.46%	0.53%	0.49%	0.63%	0.58%	0.33%	0.35%	0.31%
TORNTPHARM.NS Torrent Pharmaceuticals Limited	1.01%	0.83%	0.83%	0.95%	1.06%	1.07%	0.61%	0.92%	0.79%	0.99%	2.66%	0.77%

Financials

Frequently Asked Questions

Can I hold both CIPLA.NS and TORNTPHARM.NS in my portfolio?

CIPLA.NS and TORNTPHARM.NS have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.